Also, in the test with subcutaneous GnRH analogs, in which a measurement at least 180 min after injection is usually required [24,25], samples at 30 min [26] or 60 min [27] were found to be a reliable alternative for diagnosing CPP. This evidence concerns the gene GNRH1 and central precocious puberty.